国际医学
(000516)
| 流通市值：113.77亿 | | | 总市值：115.53亿 |
| 流通股本：22.05亿 | | | 总股本：22.39亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 471,603,381.91 | 590,562,003.38 | 427,482,946.42 | 667,259,133.82 |
| 应收票据及应收账款 | 690,857,166.93 | 739,394,118 | 753,350,686.68 | 657,946,126.8 |
| 应收账款 | 690,857,166.93 | 739,394,118 | 753,350,686.68 | 657,946,126.8 |
| 预付款项 | 17,538,655.63 | 14,918,233.92 | 11,988,100.36 | 14,035,181.8 |
| 其他应收款合计 | 52,779,427.21 | 51,207,494.92 | 52,521,289.37 | 45,885,343.04 |
| 存货 | 63,274,718.58 | 81,005,105.26 | 98,559,720.86 | 74,474,137.08 |
| 其他流动资产 | 45,613,793.28 | 48,913,918.86 | 45,185,154.8 | 46,614,264.75 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,357,462,403.54 | 1,615,075,051.84 | 1,461,576,314.49 | 1,553,510,887.29 |
| 非流动资产: | | | | |
| 长期股权投资 | 1,943,967.4 | 1,377,139.03 | 977,482.54 | 1,323,368.4 |
| 其他非流动金融资产 | 242,698,087.66 | 244,233,241.25 | 217,546,338.44 | 212,426,497.72 |
| 投资性房地产 | 16,071,429.87 | 16,399,190.37 | 26,670,044.29 | 26,997,804.79 |
| 固定资产 | 7,130,759,271.38 | 7,285,642,716.34 | 7,387,645,692.22 | 7,539,482,617 |
| 在建工程 | 358,097,896.28 | 328,487,804.34 | 258,247,579.31 | 248,584,518.49 |
| 无形资产 | 701,072,568.01 | 709,814,400.65 | 717,865,650.24 | 728,172,168.14 |
| 长期待摊费用 | 49,752,263.5 | 53,503,044.59 | 43,446,524.01 | 46,846,299.27 |
| 递延所得税资产 | 78,941,868.16 | 79,056,426.69 | 88,431,870.68 | 88,381,466.76 |
| 其他非流动资产 | 382,043,127.05 | 302,732,977.79 | 351,659,380.15 | 301,074,433.75 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 8,961,380,479.31 | 9,021,246,941.05 | 9,092,490,561.88 | 9,193,289,174.32 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 10,318,842,882.85 | 10,636,321,992.89 | 10,554,066,876.37 | 10,746,800,061.61 |
| 流动负债: | | | | |
| 短期借款 | 850,873,159.34 | 823,166,366.96 | 617,504,881.56 | 527,905,355.34 |
| 应付票据及应付账款 | 1,769,520,432.76 | 1,843,264,695.51 | 1,862,914,735.93 | 1,965,706,063.27 |
| 其中：应付票据 | 60,000,000 | - | - | - |
| 应付账款 | 1,709,520,432.76 | 1,843,264,695.51 | 1,862,914,735.93 | 1,965,706,063.27 |
| 预收款项 | 526,258.6 | 411,603.1 | 259,105.2 | 365,259.92 |
| 合同负债 | 231,705,493.35 | 231,254,869.54 | 218,476,442.86 | 221,256,370.82 |
| 应付职工薪酬 | 157,403,234.56 | 218,876,161.02 | 209,103,355.43 | 173,635,357.51 |
| 应交税费 | 19,751,471.73 | 24,556,058.99 | 26,033,207.34 | 26,713,828.8 |
| 其他应付款合计 | 184,578,102.96 | 193,580,373.8 | 239,438,093.33 | 203,733,753.77 |
| 应付股利 | 1,209,363.18 | 1,209,363.18 | 1,209,363.18 | 1,209,363.18 |
| 一年内到期的非流动负债 | 860,900,139.14 | 816,369,733.87 | 757,592,177.59 | 788,183,123.82 |
| 其他流动负债 | 4,963.6 | 5,620.05 | 11,257.92 | 10,840.79 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 4,075,263,256.04 | 4,151,485,482.84 | 3,931,333,257.16 | 3,907,509,954.04 |
| 非流动负债: | | | | |
| 长期借款 | 2,887,370,673.41 | 2,996,791,673.38 | 3,130,250,685.58 | 3,283,518,352.22 |
| 长期应付款 | 99,597 | 99,597 | 99,597 | 99,597 |
| 预计负债 | 9,586,483.52 | 8,334,524.94 | 7,540,000 | 7,568,200 |
| 递延收益 | 5,092,818.65 | 5,220,673.71 | 4,517,308.85 | 3,933,486.6 |
| 递延所得税负债 | 2,400,000 | 2,400,000 | 1,800,000 | 1,800,000 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 2,904,549,572.58 | 3,012,846,469.03 | 3,144,207,591.43 | 3,296,919,635.82 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 6,979,812,828.62 | 7,164,331,951.87 | 7,075,540,848.59 | 7,204,429,589.86 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 2,260,382,715 | 2,260,382,715 | 2,260,382,715 | 2,260,809,518 |
| 资本公积 | 1,062,888,908.95 | 1,062,888,908.95 | 1,059,514,188.37 | 1,059,771,528.6 |
| 减:库存股 | 69,017,805.61 | 69,017,805.61 | 129,974,045.42 | 132,261,709.5 |
| 盈余公积 | 400,702,384.75 | 400,702,384.75 | 400,702,384.75 | 400,702,384.75 |
| 未分配利润 | -86,382,306.78 | 19,971,552.1 | 61,991,076.4 | 100,494,216.57 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 3,568,573,896.31 | 3,674,927,755.19 | 3,652,616,319.1 | 3,689,515,938.42 |
| 少数股东权益 | -229,543,842.08 | -202,937,714.17 | -174,090,291.32 | -147,145,466.67 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 3,339,030,054.23 | 3,471,990,041.02 | 3,478,526,027.78 | 3,542,370,471.75 |
| 负债和股东权益合计 | 10,318,842,882.85 | 10,636,321,992.89 | 10,554,066,876.37 | 10,746,800,061.61 |
| 公告日期 | 2025-04-23 | 2025-04-23 | 2024-10-25 | 2024-08-28 |
| 审计意见(境内) | | 标准无保留意见 | | |